ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate
Clinical trial NCT02106507 · COMPLETED
Trial details
- NCT number
- NCT02106507
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2021-06-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.